Nivalis Therapeutics, Inc. (ALPN)
(Delayed Data from NSDQ)
$6.24 USD
-0.08 (-1.27%)
Updated May 3, 2019 03:59 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
[ALPN]
Reports for Purchase
Showing records 61 - 80 ( 156 total )
Industry: Medical - Drugs
Industry: Medical - Drugs
First Look at ALPN-303; Early Profile Suggests Best in Class Potential
Provider: Wedbush Securities Inc.
Analyst: DRISCOLL R
Industry: Medical - Drugs
Two Birds, One Stone; Data Highlight ALPN-303''s Potential As a Dual BAFF/APRIL Antagonist
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Industry: Medical - Drugs
Industry: Medical - Drugs
Industry: Medical - Drugs
Industry: Medical - Drugs
NEON-2 Receives Green Light From the FDA to Push On; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Industry: Medical - Drugs
Industry: Medical - Drugs
Industry: Medical - Drugs
Q1 Financials; First Look at ALPN-303 in Clinic at EULAR
Provider: Wedbush Securities Inc.
Analyst: DRISCOLL R
Industry: Medical - Drugs
1Q22 Results; Strong Cash Supporting Pipeline; NEON-1 Open for Enrollment, ALPN-303 Initial Data Mid-2022
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Industry: Medical - Drugs
ASCO 2022 Abstract Titles for Covered Companies
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Industry: Medical - Drugs
Robust Davoceticept Dose-Escalation Dataset Supports Next Steps
Provider: Wedbush Securities Inc.
Analyst: DRISCOLL R
Industry: Medical - Drugs
Industry: Medical - Drugs
NEON-1 Illuminates Davoceticept''s Way Forward at AACR
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Industry: Medical - Drugs
Davoceticept?s 3x1 Strategy Corroborates Promising Preclinical Efficacy Ahead of NEON-1 Readout at AACR
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Industry: Medical - Drugs
Industry: Medical - Drugs
Q4 Financials; Updated Look at Davoceticept Ahead at AACR
Provider: WEDBUSH SECURITIES INC.
Analyst: DRISCOLL R
Industry: Medical - Drugs
2021 Results; NEON-1 Update at AACR Kicks Off a Year of Anticipated News Across All Programs
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Industry: Medical - Drugs
AACR 2022 Abstract Roundup For Covered Companies
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D